Business
Idorsia welcomes Amer Joseph as new Chief Medical Officer and Head of Global Clinical Development
Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP, Chief Medical Officer & Head of Global Clinical Development, becoming a member of the Idorsia Executive Committee Allschwil, Switzerland – April 9, 2026Idorsia Ltd (SIX: IDIA) announces the appointment of Dr Amer Joseph as Executive Vice President, Chief Medical Officer (CMO) & Head of Global Clinical D
About this update from Idorsia Ltd.
[{"type":"image","alt":"Idorsia Pharmaceuticals Ltd","displaySize":"","headline":null,"caption":"Idorsia Pharmaceuticals Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":138,"url":"https://media.zenfs.com/en/globenewswire.com/78a4ac48860a5805262d0e653fb52e9a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hFCnMmy9Ihh7UbzaqwJr7A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5Mw--/https://media.zenfs.com/en/globenewswire.com/78a4ac48860a5805262d0e653fb52e9a","width":300,"height":138}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Idorsia thanks Alberto Gimona – most recently Head of Global Clinical Development and Medical Affairs – and wishes him all the best for a well-deserved retirement","length":162,"tagName":"p"}]},{"val":[{"type":"text","content":"Amer Joseph joins Idorsia as EVP, Chief Medical Officer & Head of Global Clinical Development, becoming a member of the Idorsia Executive Committee","length":151,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":313,"olType":false},{"type":"text","content":"Allschwil, Switzerland – April 9, 2026Idorsia Ltd (SIX: IDIA) announces the appointment of Dr Amer Joseph as Executive Vice President, Chief Medical Officer (CMO) & Head of Global Clinical Development, effective May 1, 2026. He succeeds Dr Alberto Gimona, who is retiring.","length":277,"tagName":"p"},{"type":"text","content":"Amer is an accomplished clinical development leader with a strong track record of delivering regulatory filings, executing mid‑ and late‑stage global clinical development programs, building high‑performing teams, and driving operational excellence with clarity, discipline and speed. His leadership – rooted in scientific rigor, curiosity, and a strong sense of ownership – reflects Idorsia’s culture of innovation, agility, and purposeful execution.","length":450,"tagName":"p"},{"type":"text","content":"As CMO & Head of Global Clinical Development, Amer will lead global clinical strategy and execution across all therapeutic areas, as well as ensure medical governance, helping to advance Idorsia’s pipeline and shape the company’s scientific and medical direction.","length":267,"tagName":"p"},{"type":"text","content":"Jean-Paul Clozel, MD, Chairman and interim CEO of Idorsia commented:“I’m delighted to welcome Amer to Idorsia. His breadth of clinical de...